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bSrivastava, Department of Radiodiagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, IndiaAbstractPurpose: To evaluate prospectively the role and impact of multidetector row computed tomography (MDCT) before bronchial artery
embolization (BAE) in patients with hemoptysis.
Methods: MDCT of the thorax was performed in 27 patients (21 men, 6 women; age range, 22-70 years; mean, 39 years) with hemoptysis
who were referred for BAE. Transverse, multiplanar reconstruction, and 3-dimensional reconstruction (maximum intensity projection and
volume rendered) images were analysed to identify the abnormal hypertrophied bronchial and nonbronchial systemic arteries causing
hemoptysis, their origin and course were noted. Digital subtraction angiography was performed with the knowledge of findings of MDCT.
Selective arteriogram of abnormal bronchial as well as nonbronchial arteries was performed. Embolization was attempted in 25 of these
patients (92.6%) by using polyvinyl alcohol particles (350-500 mm), Gelfoam or Embospheres (400-700 mm). Follow-up was done for a mean
period of 20.5 months.
Results: Based on MDCT, 2 of 27 patients were found unsuitable for BAE. On computed tomography, 38 arteries (27 bronchial and
11 nonbronchial systemic arteries) were identified as abnormal hypertrophied vessels. On angiography, 34 of these arteries (25 bronchial and
9 nonbronchial systemic arteries) were found to be responsible for hemoptysis. Three of these arteries could not be evaluated during
angiography, and 1 artery that was identified as abnormal on computed tomography was found normal on angiography. All 25 bronchial and
9 nonbronchial systemic arteries that cause hemoptysis were detected at MDCT. Embolization was successful in 23 of 25 patients.
Conclusion: MDCT enables detection and depiction of all bronchial and nonbronchial systemic arteries causing hemoptysis.ResumeObjectif : Evaluer de fac¸on prospective le ro^le et les consequences de la tomodensitometrie (TDM) a detecteurs multiples avant une
embolisation d’arteres systemiques bronchiques et non bronchiques chez les patients presentant une hemoptysie.
Methodes : Une TDM a detecteurs multiples du thorax a ete realisee chez 27 patients (21 hommes et 6 femmes; plage d’a^ge de 22 a 70 ans;
a^ge moyen de 39 ans) presentant une hemoptysie et ayant ete orientes en tomodensitometrie pour subir une embolisation d’arteres
systemiques bronchiques et non bronchiques. Des images transversales, de reconstruction multiplanaires et de reconstruction en trois
dimensions (obtenues par projection d’intensite maximale et rendu volumique) ont ete analysees afin de reperer les arteres systemiques
bronchiques et non bronchiques anormalement hypertrophiees causant l’hemoptysie. L’origine et l’evolution de ces anomalies ont ete notees.
Une angiographie numerique par soustraction a ete realisee suivant les resultats de la TDM a detecteurs multiples. On a egalement effectue
une arteriographie selective des arteres bronchiques et non bronchiques anormales. Une embolisation a ete tentee chez 25 de ces patients
(92,6 %) a l’aide d’alcool polyvinyle (de 350 a 500 mm), de Gelfoam ou d’Embosphere (de 400 a 700 mm). Ceux-ci ont ete suivis durant une
periode moyenne de 20,5 mois.
Resultats : A la suite de la TDM a detecteurs multiples, on a juge qu’une embolisation d’arteres systemiques bronchiques et non bronchiques
etait contre-indiquee chez 2 des 27 patients. A la TDM, 38 arteres (27 arteres systemiques bronchiques et 11 non bronchiques) sont apparues* Address for correspondence: Deep Narayan Srivastava, MD, Department
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62 M. Gupta et al. / Canadian Association of Radiologists Journal 64 (2013) 61e73anormalement hypertrophiees. L’angiographie a revele que 34 de ces arteres (25 arteres systemiques bronchiques et 9 non bronchiques)
etaient a l’origine de l’hemoptysie. Trois de ces arteres n’ont pu e^tre evaluees durant l’angiographie, et une artere qui etait anormale selon la
tomodensitometrie s’est averee normale a la lecture de l’angiographie. La TDM a detecteurs multiples a permis de detecter les 25 arteres
systemiques bronchiques et les 9 non bronchiques a l’origine de l’hemoptysie. L’embolisation a produit les resultats voulus chez 23 des
25 patients.
Conclusion : La TDM a detecteurs multiples permet la detection et la representation de toutes les arteres systemiques bronchiques et non
bronchiques causant une hemoptysie.
 2013 Canadian Association of Radiologists. All rights reserved.
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occur due to a wide variety of causes. Common causes of
hemoptysis are tuberculosis (either active or its sequelae),
bronchiectasis (due to other causes), aspergilloma, and
bronchogenic carcinoma. In situations in which surgery will
eliminate the cause of hemoptysis, it is the treatment of
choice. However, many of these patients are not surgical
candidates due to diffuse pulmonary disease, poor pulmonary
reserves, or poor general condition. Moreover, surgical
management in the acute situation is associated with high
mortality and high morbidity.
In 1973, Remy et al [1] performed the first bronchial
artery embolization (BAE) for the control of hemoptysis.
Since then, BAE has found widespread acceptance as
a measure to control hemoptysis in inoperable cases or in
patients who are unstable before surgery. Although BAE is
commonly used for treating massive hemoptysis, chronic
recurrent mild and recurrent hemoptysis, which disturbs the
life style of the patient and is not amenable to surgical
treatment, also is increasingly being treated with BAE.
In patients with an episode of hemoptysis, rapid identifica-
tion of the site and the cause of bleeding with noninvasive
imaging techniques before the use of interventional procedures
is important.Diagnostic studies formassive hemoptysis include
radiography, bronchoscopy, and CT of the chest. Introduction
of helical CT with dynamic contrast-enhanced study led to
many studies in the past years to depict the site of bleeding as
well as identification of abnormal bronchial ateries [2].
However, more recently, after the advent of MDCT, various
retrospective studies [3e5] have shown the utility ofMDCTCT
angiography (CTA), but no prospective studies exist. CTA is
currently the standard of care in the management of patients
with hemoptysis [6]. Therefore, the utility of this current study
is to prospectively validate what has evolved into the current
standard of care. to show the usefulness of the information
provided by MDCT in therapeutic decisions in patients with
hemoptysis. So, we undertook this prospective study to show
the clinical impact of MDCT in patients with hemoptysis.
Material and Methods
As per the following inclusion and exclusion criteria,
27 patients who presented with massive, moderate, or
recurrent hemoptysis, and were referred to our departmentfor BAE were included in this study. These patients were
assessed by using MDCT before digital subtraction angiog-
raphy (DSA) and BAE. Institutional ethical committee
approval was not obtained because it was not mandatory at
that point of time. However, ethical clearance was obtained
from a departmental committee, and informed consent was
obtained from every patient.
Inclusion criteria were the following: (1) patients with
severe hemoptysis defined as blood lossmore than 300mL/d or
more, or (2) patients with recurrent bouts of moderate
hemoptysis defined as 3 or more bouts of blood loss of more
than 100 mL/d within a week, or (3) patients with chronic
recurrent small-volume (<100 mL/d) hemoptysis that inter-
fered with the patient’s lifestyle and/or prevents effective
physical therapy. Patients who were good surgical candidates
with resectable lesion, those for whom angiography was
contraindicated (eg, contrast allergy, renal function abnor-
malities, bleeding diathesis), and patients <18 years of age
were excluded from the study.
At the time of first contact with the patient, a detailed
history was obtained. The amount of blood expectorated in
the last 48 hours was recorded. In the patient with recurrent
hemoptysis, a history was taken, inquiring about the number
of episodes in the past 6 months and the amount of blood
expectorated in each episode.
MDCT was performed with a 4-row detector CT scanner
(volume zoom; 140 kV, 60-100 mAs, rotation time of
0.5 second, 1-mm collimation; Siemens Medical Solutions,
Erlangen, Germany) in 22 patients and with a 16edetector
row scanner (140 kV, 70-120 mAs, rotation time of 0.5
second, 0.75-mm collimation; Sensation 16 [Siemens]) in the
remaining 5 patients. All the patients underwent caudocra-
nial scanning in a supine position at end inspiratory
suspension during a single breath hold. All the patients
received 70-100 mL (total 30 g) of nonionic contrast material
with 300 mg of iodine per milliliter, which was administered
intravenously into the antecubital vein through an 18-gauge
catheter at a rate of 3.5 mL/s by using an automated
injector. Scan delay time was chosen between 18-24 seconds
in a 4edetector row scanner. For the 16edetector row scanner,
the automatic bolus triggering software program was
systematically applied, with a circular region of interest
positioned at the level of the descending thoracic aorta just
below the carina and a threshold for triggering data acquisition
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acicinlet to the lower border of L2 level to include celiac and
phrenic arteries. For CTA reconstruction was done at 1-mm
slice thickness, with 0.6-mm increment. Reconstruction was
done in maximum intensity projection, multiplanar reforma-
tion, and 3-dimensional volume rendered (VR) images.CT AnalysisFirst, CTwas analysed to look for the cause of hemoptysis
and to localize the site of hemoptysis. Images were viewed in
the lung and mediastinal window to look for parenchymal
changes, any lymphadenopathy, pleural thickening, and
major vessels.
Analysis of Bronchial Arteries
CT interpretation was done by using axial images, mul-
tiplanar reformation images, and 3-dimensional reconstruc-
tions (maximum intensity projection and VR) images to
identify bronchial arteries, and the following parameters
were recorded: (a) the total number of bronchial arteries per
side; (b) the site of the ostium of the bronchial artery (or
arteries); (c) location of the ostium on the wall of the
descending aorta (ie, posterior, medial, anterior, or lateral),
and its position relative to the tracheal carina, (d) bronchial
artery diameter; (e) visualized course of bronchial arteries.
Bronchial arteries were considered abnormal when (a) the
diameter of the bronchial artery was 2 mm, or (b) the
course of the bronchial artery was visualized up to the hilum.
The bronchial artery that satisfied either or both of these
criteria was considered an abnormal hypertrophied artery and
as a source of hemoptysis.
The origin of bronchial artery was considered orthotopic
when the origin was from the descending aorta between the
levels of the T5 and T6 vertebrae and ectopic when identified
at a level of the descending aorta other than the expected origin
(ie, outside levels T5-T6) or from any aortic branch vessel.
Analyses of Nonbronchial Systemic Arteries
Arteries that enter the lung parenchyma through the
inferior pulmonary ligament or through the adherent pleura
and with trajectories that are not parallel to the bronchi are
considered as nonbronchial arteries. They were considered
abnormal when they become dilated and tortuous, and were
seen within extrapleural fat in association with pleural
thickening (3 mm) and/or lung parenchyma abnormalities.
Whenever an abnormal nonbronchial systemic artery was
identified, its origin and course was noted.Angiography and EmbolizationIn all the patients, DSA was performed within a median
period of 5 days (range, 0-25 days) after CT, depending upon
the clinical condition of the patient; 70-120 mL of nonionic
(iohexol [Omnipaque; GE Healthcare, Princeton, NJ])
contrast agent was used in all the patients. A preliminary
flush thoracic aortogram was performed to identify thebronchial arteries and systemic collaterals. We noted the
number, origin, and course of bronchial arteries visualized on
flush aortogram.
Angiographic procedures were performed with the
knowledge of CT findings. Flush aortogram was followed by
selective bronchial artery catheterization. For selective
bronchial engagement, 5F/4F curved catheters such as the
Simmons, celiac, picard, and renal double curve were used,
and microcatheters were used when required. Arteriography
also was done for nonbronchial systemic arteries when
required. Abnormal bronchial arteries and nonbronchial
systemic arteries were embolized. Embolic materials used
were the following: polyvinyl alcohol (PVA) (size, 350-550
mm; Boston Scientific Ireland Ltd, Galway, Ireland, or Cook
Medical, Bloomington, IN), Gelfoam and Embosphere (size,
500-700 mm; Biosphere Medical S A, Etoile; Roissy on
France, UK). Gelfoam was never used as the only embolic
agent in any of the patients.
The following angiographic findings were considered
to be predictive of the vessels responsible for hemoptysis:
(a) tortuous enlargement of bronchial and/or nonbronchial
systemic arteries that supplied the area of parenchymal
staining, and (b) a shunt into pulmonary vessels. The results
of angiography were compared with the results of MDCT.Follow-upFollow-up was done for a mean of 20.5 months to know
about any recurrent bout of hemoptysis by clinical assess-
ment. Follow-up CT also was performed in 1 patient to
follow up a small subintimal dissection that occurred during
the embolization procedure.
Results
In the study population, the most common cause of
hemoptysis was sequelae of prior tuberculous infection
(51.8%). Five of these patients also had aspergillomas. The
second most-frequent cause was bronchiectasis (22.2%) due
to another cause. Twenty-four patients (88.9%) presented
with either massive or recurrent moderate hemoptysis.CTA
Bronchial arteries
In this study, we found 27 abnormal bronchial arteries
(17 right bronchial arteries and 10 left bronchial arteries).
The diameter of the abnormal right bronchial arteries ranged
from 2.2-4.3 mm (mean, 2.9 mm) (Figure 1). The diameter of
abnormal left bronchial arteries ranged from 2-5 mm (mean,
2.9 mm) (Figures 2-4). Among the 27 abnormal bronchial
arteries, the origin of 17 (63%) were found to be at the T5
level. An important observation was that MDCT detected
2 abnormal arteries (7.4%) with ectopic origin, that is, at
a level other than T5 or T6 (Figure 5). Among right bronchial
arteries, the origin of 16 arteries (94.2%) was found from the
medial wall of the aorta, whereas the left bronchial was
Figure 1. (A) High-resolution computed tomography, showing bronchiectasis (white arrows) that involve the apical segment of the bilateral lower lobes.
(B) Volume rendered image shows hypertrophied right bronchial artery (black arrow), originating from the T6 level. (C) Axial maximum intensity projection
(MIP), showing the origin of the right bronchial artery (black arrow) from the medial wall of aorta. (D) Coronal MIP image, showing a hypertrophied right
bronchial artery (white arrow). (E) Selective arteriogram, showing an hypertrophied and tortuous right bronchial artery (black arrow). Embolization was done
with polyvinyl alcohol 400-600 mm. This figure is available in colour online at http://carjonline.org/.
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(70.0%) of the aorta.
Nonbronchial systemic arteries
In addition to the bronchial arteries, MDCT also identified
nonbronchial systemic arteries in 11 of 27 patients (40.7%).
Among these 11 patients, 10 (90.9%) had pleural thickening
(Figures 6, 7). Only 1 patient with abnormal nonbronchial
artery had normal pleura. This patient was diagnosed to have
an unusual cause of hemoptysis, that is, an aberrant vessel
supplying a normal segment of the left lower lobe (type
1 Pryce intralobar sequestration) (Figure 8). Among the
11 patients with abnormal nonbronchial systemic arteries,
3 patients (11.1%) had normal bronchial arteries, and the
nonbronchial systemic arteries were the only source of
hemoptysis.
After the preprocedural evaluation by MDCT, 25 patients,
of a total of 27 patients, were selected for BAE. The reasons
for not performing BAE in 2 patients were as follows. The
first patient had a history of wedge resection of the left upperlobe for hemoptysis. A diagnosis of fibrosis of the left upper
lobe was made with high-resolution CT (HRCT) of the lung
at that time. After MDCT and CTA, we made the diagnosis
of an anomalous vessel supplying the segment of the left
lower lobe (type 1 Pryce intralobar sequestration). The cause
of hemoptysis in this condition is focal pulmonary hyper-
tension, and embolization of abnormal vessel may actually
worsen the hemoptysis. Surgery is considered to be the
suitable treatment for this condition. Embolization was not
performed. DSA was performed in this patient only for
diagnostic purpose.
The second patient in whom embolization was not per-
formed, came with the diagnosis of right lower lobe fibrosis
based on his previous chest radiograph and HRCT of the
lung. After MDCT and CTA, the diagnosis of chronic
pulmonary thromboembolism that involved the right
descending pulmonary artery with systemic to pulmonary
collaterals was made (Figure 9). The cause of hemoptysis in
this condition was pulmonary infarctions or the breakdown
of systemic pulmonary collaterals. Embolization of the
Figure 2. (A) High-resolution computed tomography, demonstrating cystic bronchiectasis predominantly that involves the left lower lobe (black arrow), with
less-pronounced involvement of the lingula and middle lobe (white arrow). (B) Volume rendered image, demonstrating a hypertrophied left bronchial artery
(white arrow) arising from the aorta. (C) Axial section, showing the origin of this artery (white arrow) from the anterior wall of aorta. (D) Selective arteriogram
of this artery confirms the presence of hypertrophied artery with tortuous course (short black arrow) with parenchymal staining (long black arrows). This figure
is available in colour online at http://carjonline.org/.
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embolization in these cases is only warranted if hemoptysis
is life threatening. Hence, the patient was put on medical
conservative therapy to control recurrent hemoptysis instead
of BAE. Hence, of the total 27 patients who were referred for
BAE, preprocedural MDCT changed the management in
2 patients (7.4%).DSATwenty-five bronchial arteries and 9 nonbronchial
systemic arteries were found to be abnormal on angiography.
When comparing the findings with MDCT, all the bronchial
arteries were prospectively identified as abnormal by MDCT.
Three of the arteries that were found to be abnormal onMDCT could not be evaluated on DSA. In 1 of these
patients, DSAwas not performed. The other 2 arteries (1 left
intercostal and 1 right bronchial) could not be selectively
catheterized and hence could not be evaluated. One non-
bronchial artery (left lateral thoracic artery), which was
found abnormal on MDCT, was found normal on DSA. Of
34 abnormal arteries, 33 arteries were embolized. One of the
patients had sequestration, and, as described above, DSA in
this patient was performed for diagnostic purposes only.
Of 25 patients in whom BAE was attempted, embolization
could not be performed in 2 patients. In 1 of these patients,
no abnormal vessel was found on either CTA or DSA. The
diagnosis in this patient was active pulmonary tuberculosis,
and the patient was treated with antitubercular therapy. In the
second patient, we could not superselectively catheterize an
Figure 3. (A) Volume rendered image, showing a hypertrophied left bronchial artery (black arrow) and a right bronchial artery (white arrow), arising close
to each other. (B) Selective arteriogram of the left bronchial artery, showing dilated tortuous artery (white arrow) with parenchymal staining (black arrows).
(C) Selective arteriogram of the right bronchial artery (white arrow), showing mild parenchymal staining (black arrow) in the region of the apical segment of
the right lower lobe. This figure is available in colour online at http://carjonline.org/.
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MDCT.
A total 25 bronchial arteries were embolized during the
procedure. Of these 25 bronchial arteries, 4 bronchial arteries
(16%) were not adequately visualized on flush aortogram. Of
these bronchial arteries, 3 arteries were not visualized at all,
and only parenchymal staining was seen, and, in the fourth
case, only the distal part of the vessel was visualized
(Figure 5C). The reason that they were inadequately visu-
alized was that their origins were either anterior or posterior,
and hence were not seen on frontal flush aortogram due to
overlapping. However, due to prior knowledge of the
anatomy on MDCT, selective catheterization could easily be
done in all of these arteries.Discussion
BAE is commonly used for treating massive hemoptysis.
In addition, chronic recurrent mild and recurrent hemoptysis
that disturbs the life style of the patient and is not amenable
to surgical treatment also is increasingly being treated with
BAE [7]. In patients with an episode of hemoptysis, finding
the source and site of hemoptysis before the BAE procedure
is very important and can direct a more focused and efficient
procedure. Diagnostic studies for massive hemoptysis
include radiography, bronchoscopy, and CT of the chest. CT
is a useful method to identify and depict the bronchial artery
and to predict the presence of nonbronchial systemic vessels
that supply a parenchymal lesion. Therefore, depicting
bronchial arteries with CT before performing interventional
procedures could provide useful information and direction
for bronchial arterial interventional procedures. In our study,
we have made an attempt to evaluate the role of MDCT fordiagnosis and management planning in patients with
hemoptysis before BAE.
CT is a useful method to use to identify and depict the
bronchial artery. Furuse et al [2] in 1987 first performed
dynamic CT in patients with enlarged bronchial arteries. He
showed that the mediastinal portion of bronchial arteries was
successfully outlined as nodular or linear densities. MDCT
has the advantage that it not only can detect but also can
accurately depict the origin and course of bronchial arteries.
A bronchial artery diameter larger than 2 mm was considered
abnormal. In our study, a cutoff of 2 mm was taken as
a diameter of abnormal bronchial arteries on MDCT. A
diameter of abnormal right bronchial arteries ranged from
2.2-4.3 mm (mean, 2.9 mm), and abnormal left bronchial
arteries ranged from 2-5 mm (mean, 2.9 mm). To our
knowledge, there is only one other study that compared the
diameter of abnormal bronchial arteries detected on MDCT
with findings on angiography. Yoon et al [3] retrospectively
reviewed MDCT in patients with hemoptysis who had
undergone BAE, and, in their study, the diameter of bron-
chial arteries, which were abnormal on angiography, ranged
from 1.3-4.7 mm (mean, 2.8 mm). Also, 8 bronchial arteries
causing hemoptysis were <2 mm. However, in our study,
a cutoff value of 2 mm on MDCT prospectively detected all
abnormal bronchial arteries as detected later with DSA.
There is only one other study that compared the diameter of
abnormal bronchial arteries with findings on DSA.
We were able to demonstrate the origin and course of all
the abnormal arteries up to the hilum. In addition, we also
were able to detect and depict the course of bronchial arteries
of ectopic origin. These branches, sometimes referred to as
bronchial arteries of anomalous origin, were defined as
arteries that originate from the descending aorta outside the
T5-T6 level, with an intrapulmonary course along the major
Figure 4. (A) High-resolution computed tomography, showing destroyed left lung with fibrocavitatory lesions (black arrows). (B) Volume rendered image,
showing the common bronchial trunk (black arrow) with hypertrophied left branch (white arrow). The right bronchial artery (white arrowhead), demonstrating
normal calibre. (C) Selective arteriogram of the common bronchial trunk (black arrowhead), demonstrating hypertrophied left branch (white arrow), with
marked systemic to pulmonary shunting, which caused early opacification of the pulmonary artery (black arrow). This figure is available in colour online at
http://carjonline.org/.
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arteries, as depicted on CT, were orthotopic in 25 bronchial
arteries (92.6%), whereas, it was ectopic in 2 bronchial
arteries (7.4%) (Figure 7E). The reported prevalence of
bronchial arteries with an anomalous origin ranges from
8.3%-35% [8,9]. Remy et al [10] demonstrated 4 of 23 right
arteries (17%) and 8 of 30 left arteries (27%) as ectopic on
CT angiograms. In their retrospective study, Yoon et al [3]
depicted 5 bronchial arteries (9.6%) as ectopic on CT.
None of these arteries were selectively catheterized during
DSA. It highlights the importance of knowing the presence
of ectopic bronchial arteries before intervention. In our study,
2 abnormal ectopic arteries were found on CTA, both of
them were easily catheterized by using CT information and
embolized. Thus, the anatomic information provided by CT
angiograms helped in the guidance of successful catheteri-
zation and rapid embolization of orthotopic as well as
ectopic bronchial arteries.
The origin of 16 of 17 right bronchial and intercosto-
bronchial arteries (94.2%) was from medial wall (Figure 1C),and 7 of 10 left bronchial arteries (70%) were from the
anterior wall of aorta (Figure 2C). Our study confirmed the
findings that the majority of right bronchial arteries arise in
the medial wall of the descending aorta, whereas most left
bronchial arteries arise in the anterior wall of the descending
aorta [2,3,10].
One of the major causes of recurrent hemoptysis after
successful embolization of bronchial arteries is the presence
of abnormal nonbronchial systemic arteries. We identified
nonbronchial systemic arteries in 11 of 27 patients (40.7%)
(Figures 4, 5). Three of these patients (11.1%) had normal
bronchial arteries, and a nonbronchial systemic artery was
the only source of hemoptysis. In a study by Goh et al [11] of
103 patients who underwent BAE, 42 had nonbronchial
systemic contributions (41%) and 12 had abnormal non-
bronchial systemic arteries but normal bronchial arteries
(11.7%). Wong et al [12] found that nonbronchial collateral
vessels supplied the bleeding area in 14 of 16 patients with
life-threatening hemoptysis (88%). In 3 of those 16 patients
(19%), bleeding from systemic vessels other than the
Figure 5. (A) Volume rendered image, showing hypertrophied left bronchial artery (black arrow) originating from the posterior wall of the aorta at the T7 level
and going superiorly. (B) Selective arteriogram of the left bronchial artery (black arrowhead), demonstrating a hypertrophied artery with parenchymal staining
(white arrow) and pulmonary shunting (black arrow). (C) Flush aortogram, showing intense parenchymal staining in the left upper zone (black arrow). However,
the origin as well as the trunk of left bronchial artery is not seen in frontal aortogram. This figure is available in colour online at http://carjonline.org/.
Figure 6. (A) High-resolution computed tomography (CT), showing cystic bronchiectasis that involves the middle lobe (white arrow) and the left lower lobe
(black arrow). (B) Axial CT, showing increased vascularity along the right hemi-diaphragm (black arrow). (C) Maximum intensity projection image, showing
hypertrophied right inferior phrenic artery (white arrow) originating from the lateral wall of aorta. (D) Selective arteriogram of the inferior phrenic artery (black
arrow), showing an abnormal dilated tortuous course with parenchymal staining.
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Figure 7. (A)High-resolution computed tomography, showing a cavitywith aspergilloma (white arrow) in the right apex, with pleural thickening (black arrow) and
with paraseptal emphysema with bilateral interstitial fibrosis. (B) Volume rendered image, showing hypertrophied right lateral thoracic artery (white arrow).
(C) Selective arteriogram of this vessel, showing abnormal parenchymal staining (black arrow). This figure is available in colour online at http://carjonline.org/.
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et al [13] controlled hemoptysis in 3 patients by embolizing
only the intercostal arteries. In the study by Hashimoto et al
[14], massive hemoptysis was caused by internal mammary
artery contributions to the perfusion of lesions in 5 of 13
patients. Thus, our study also corresponds with these studies
and confirms the significant contribution of nonbronchial
systemic arteries in patients with hemoptysis. Embolization
of the nonbronchial systemic arterial supply can lower the
immediate recurrence rate after successful embolization.
Therefore, it is important to identify these abnormal non-
bronchial systemic arteries before embolization.
MDCT angiography also can depict the course and origin
of an abnormal vessel. Yoon et al [3] also reported abnormal
nonbronchial systemic arteries in 8 of their 22 patients when
using MDCT (36.7%). Exploration of all nonbronchial
systemic arteries to find an abnormal artery followed by
selective catheterization and embolization is a difficult job
and takes a long time. The procedure time can be critical,
especially in life-threatening situations. Moreover, a long
procedure time will add to the patient’s radiation exposure
and increase the likelihood of iatrogenic and procedure-related complications. Hence, depiction and detection of
abnormal nonbronchial systemic arteries with the use of
MDCT before the procedure will help to concentrate on the
relevant artery. Knowing its anatomy, that is, its origin and
course with the help of 3-dimensional reconstructions will
help in selective catheterization of these arteries. In our
study, of 11 nonbronchial arteries that were found to be
abnormal on MDCT, 10 were easily catheterized, and 8 of
them were embolized during the procedure. Remy et al [10]
also reported that, in 3 of their patients that recurred, direct
selective catheterization and embolization of nonbronchial
systemic arteries were performed with the help of CT
angiographic findings. Thus, MDCT and CTA are helpful for
focused and efficient nonbronchial systemic artery catheter-
ization and embolization.
Along with the evaluation of systemic arteries, MDCTalso
evaluates pulmonary vasculature. Although in 95% of cases of
hemoptysis, the systemic arterial system is the origin of the
bleeding [15], pulmonary circulation can be the source of
hemoptysis in approximately 5% of cases. Detecting pulmo-
nary circulation as a source of hemoptysis before an
interventional procedure changes the approach altogether.
Figure 8. (A, B) Axial computed tomography images at 2 different levels. (A) Showing abnormal vessel arising from the aorta (a) posterior to pulmonary vein (v).
(B) Showing normal drainage of the dilated left pulmonary vein (v) into the left atrium. (C) Axial sections in the lung window, showing normal lung parenchyma
with no fibrosis, consolidation, or cyst formation. (D) Volume rendered (VR) image, showing an abnormal branch (white arrow) from the aorta supplying the
segment of the left lower lobe and the dilated left inferior pulmonary vein (white arrowhead). (E) VR image, demonstrating an abnormal branch (a) of the aorta,
which is supplying a segment of the left lower lobe through its branches (5). Any of the branches of left pulmonary artery (1-4) is not supplying this segment (5)
(superior [s] and inferior [i] left pulmonary veins). (F) Selective arteriogram of this abnormal branch confirms the arterial supply by this artery to a segment of the
left lower lobe (black arrows). (G) Delayed phase, showing opacification of the left inferior pulmonary vein (black arrow) suggestive of drainage of this segment.
This figure is available in colour online at http://carjonline.org/.
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include pulmonary emboli, Rasmussen aneurysm, direct
invasion by neoplastic disease, and rare causes such as Die-
ulafoy’s disease, and pulmonary arteriovenous malformation.
In 1 of our patients, chronic pulmonary thromboembolismwas
detected on MDCT (Figure 9), which was previouslyunsuspected. The patient had been treated being a case of right
lower lobe fibrosis due to the sequelae of tuberculosis based on
findings of his previous HRCT of the chest.
Results of previous studies also have shown that there are
chances of ischemic complication to the lung when embo-
lization of the systemic supply is attempted in the presence
Figure 9. (A) Axial contrast-enhanced computed tomography, showing hypodense thrombus (white arrow) at the right main pulmonary artery and descending
artery junction. (B) Volume rendered (VR) image, showing the division of the main pulmonary artery (M) into left (L) and right (R). There is narrowing of the
descending right pulmonary artery (white arrow) due to thrombus. (C, D, E) VR images, showing a hypertrophied right bronchial artery (black arrow), right
inferior phrenic artery (white arrow), right internal mammary artery (white arrowheads), and right lateral thoracic artery (black arrowheads). This figure is
available in colour online at http://carjonline.org/.
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Embolization has been described in cases of chronic
pulmonary thromboembolism [16], but it is only justified in
cases of life-threatening hemoptysis. A decision was made to
put the patient on conservative therapy. Thus, MDCT helped
in the diagnosis of a pulmonary cause when it was previously
unsuspected and helped in the proper management of the
patient. MDCT not only detected the pulmonary embolism,
but it also accurately demonstrated an extensive collateral
supply. Due to the presence of extensive collaterals, embo-
lization is difficult in these situations. MDCT, by displaying
the hypertrophied collaterals before the procedure, can
certainly help in planning of embolization and can add to the
efficiency of the procedure.MDCT is helpful, not only in the detection and depiction
of bronchial and nonbronchial systemic arteries causing
hemoptysis, but also for a diagnosis of alternate sources,
such as anomalous vessels seen in congenital anomalies. One
of our patients had an abnormal vessel that supplied a normal
segment of the left lower lobe (Figure 8). MDCT accurately
displayed the abnormal vessel. In addition, it also provided
other necessary information for a complete diagnosis of this
patient, namely dilated pulmonary vein (Figure 8D),
suggestive of its normal drainage, absence of pulmonary
artery supply in the segment (Figure 8E) supplying by the
vessel, and absence of any lung parenchymal abnormality in
the involved segment (Figure 8C). This entity is classified
under type 1 intralobar sequestration (purely vascular
Figure 10. (A) Coronal maximum intensity projection image, showing a hypertrophied tortuous left fifth intercostal artery (white arrow). (B) Selective
arteriogram of the left fifth intercostal artery (white arrow), showing anterior spinal artery (black arrow) originating from this trunk.
72 M. Gupta et al. / Canadian Association of Radiologists Journal 64 (2013) 61e73sequestration) in the classification suggested by Pryce [17].
Although we performed diagnostic angiography in this
patient, MDCT had provided all necessary information for
diagnosis, and, hence, the invasive procedure could be
avoided for diagnosis in these conditions.
Preliminary flush thoracic descending aortogram was
obtained in all the patients. It is useful to identify the number
and the origin sites of bronchial arteries from the aorta to
determine the optimal angiographic approach. In our study,
4 of 25 abnormal bronchial arteries (16.0%) were not seen in
flush anteroposterior aortogram; however, all of these vessels
were selectively catheterized and embolized with the help of
findings of CTA (Figure 5), so oblique flush aortograms were
not required to localize these arteries. Phillips and Ruttley
[18] showed that a descending thoracic aortogram is useful in
the detection of bronchial and nonbronchial systemic arteries
that supply parenchymal lesions. However, CTA in our study
was able to demonstrate all abnormal nonbronchial systemic
arteries. Hence, CTA can replace the routine use of prelim-
inary flush aortography before BAE for determining the
number and site of abnormal arteries. Remy et al [10] also
suggested that, thoracic aortography, an invasive procedure
still recommended by many researchers to improve the
detection of arteries that are contributing to hemoptysis,
should be replaced with CTA.
We embolized all 25 abnormal bronchial arteries (15 on
the right and 10 on the left). Apart from bronchial arteries,
we also embolized 8 nonbronchial arteries. Embolic mate-
rials that we used were PVA particles (400-600 mm or 500-
700 mm) alone or with Gelfoam, Embosphere (500-700 mm),
and coil (size 35-3-4). The majority of our cases were done
by using PVA particles alone. Three of our patients devel-
oped chest pain, and 1 developed fever, which subsided
within 5 days with conservative treatment. Most dreaded of
the complications is paraparesis due to spinal cord ischemia.
Therefore, the presence of an anterior spinal artery should
be carefully scrutinized. Inadvertent embolization of this
artery may cause spinal cord ischemia and resultant
paraplegia.One of our patients showed an anterior spinal artery on
DSA; however, we failed to visualize an anterior spinal
artery on MDCT images (Figure 10). In their retrospective
study, Remy et al [10] also searched for an anterior spinal
artery on curved maximum intensity projections at the
cervicothoracic junction but failed to visualize any on either
MDCT or angiography, hence, they could not draw any
conclusion regarding the ability of MDCT to identify ante-
rior spinal artery. We also could not see this artery on MDCT,
which shows that MDCT may not be so sensitive to detect
these arteries. However, further studies may be needed to
draw any conclusion. Immediate control of bleeding was
achieved in 22 of 25 patients (88%) in whom BAE was
attempted. Technical success could not be achieved in
2 patients. In 1 of the patients, we could not achieve a secure
selective position for embolization, and, in another patient,
no hypertrophied artery was visualized.
There were some limitations of this study. First, measure-
ment of radiation dose and fluoroscopy time during the
intervention procedure was not done, because this was not the
primary aim of this study. However, studies can be designed in
the future to compare these 2 variables in a subgroup of
patients with and without the use of MDCT before the BAE
procedure. Second, patients with significant hemodynamic
compromise were not offered MDCT before the BAE
procedure to save time before the intervention. However, we
would like to mention that the CTA does not need to be
performed on the same day as the BAE. ACTAwithin the past
1-4months is adequate for embolization planning, and, in fact,
respirologists should be encouraged to order CTA early in the
evaluation of any patient with hemoptysis who also is in need
of a diagnostic CT, so that the ‘‘map’’ is ready if or when an
urgent procedure becomes necessary.
Thus, by detecting and depicting all abnormal bronchial
and nonbronchial arteries, MDCT and CTA helped in the
planning of the embolization procedure (regarding hardware
selection such as the choice of catheter type and size, and the
amount of embolization material) depicted the anatomy of
thoracic vasculature, which was found very helpful for
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decrease the procedure time and radiation exposure to
patient. This resulted in increase in the overall efficiency of
the procedure. Moreover, by diagnosing the uncommon
causes of hemoptysis and status of pulmonary vasculature
before the intervention, MDCT guided in further manage-
ment of patient. So, we recommend routine use of MDCT
before interventional procedure in all patients of hemoptysis.
MDCT can replace the routine use of preliminary flush
aortography before BAE for determining the number and site
of abnormal arteries. Although we failed to detect an anterior
spinal artery in 1 of the patients, where we found it on DSA;
further studies are needed to know about the sensitivity of
MDCT in detection of these arteries.Clinical ImpactAlthough there is a lack of prospective studies to evaluate
the role of CTA before BAE in patients with hemoptysis, our
preliminary experience suggests that MDCT, by providing
a detailed road map of abnormal vasculature, valuable
information regarding pulmonary vasculature and detecting
uncommon causes of hemoptysis, including congenital
anomalies, has the potential to increase the overall efficiency
of the embolization procedure with a decrease in procedure
time and complication rates. As shown in our series, MDCT
guides and changes the management in a certain number of
patients. We also suggest that aortography is not necessary
after CTA, and it only results in delay, radiation, and contrast
use.
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